SANTA BARBARA, Calif. – Affinity Biosensors of Santa Barbara announced Wednesday that the diagnostic company's LifeScale AST system has received clearance from the U.S. Food and Drug Administration.

Linxens and Presto Engineering announced a strategic collaboration on a next-generation platform of connected biosensors.

Presto Engineering and Linxens collaborate on NextGen Connected Biosensor Platform Innovative platform integrating sensing, ...

According to Mordor Intelligence, the global biosensors market is valued at USD 28.50 billion in 2025 and is projected to surpass USD 42.20 billion by 2030 reflecting an 8.17% CAGR, supported by ...

Cellular Metabolism Live-Cell Assays for Research and Drug Discovery Cellular energy production depends on mitochondrial integrity and function. Mitochondrial dysfunction has been shown to alter the ...

BUFFALO, N.Y. — Early diagnosis of cancer greatly improves the odds of successful treatment. Yet many people, especially in developing countries, lack access to facilities to detect the disease. To ...

South Korean billionaire Cho Young-sik’s SD Biosensor and Seoul-based private equity firm SJL Partners said Thursday that they are acquiring Nasdaq-listed diagnostics company Meridian Bioscience for ...

WASHINGTON — An at-home COVID-19 testing kit is being recalled for failing to meet FDA requirements. The lack of FDA approval means that there is not sufficient data demonstrating that the test's ...